Canada Pension Plan Investment Board’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
33,200
+2,100
+7% +$66.2K ﹤0.01% 983
2026
Q1
$871K Sell
31,100
-20,100
-39% -$659K ﹤0.01% 1043
2025
Q4
$1.92M Buy
51,200
+47,500
+1,284% +$1.56M ﹤0.01% 947
2025
Q3
$102K Buy
3,700
+1,200
+48% +$41.3K ﹤0.01% 1190
2025
Q2
$79K Sell
2,500
-3,900
-61% -$125K ﹤0.01% 1217
2025
Q1
$212K Sell
6,400
-1,400
-18% -$50.2K ﹤0.01% 1049
2024
Q4
$268K Buy
+7,800
New +$268K ﹤0.01% 1151

Other funds holding HRMY

Canada Pension Plan Investment Board's HRMY Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Harmony Biosciences (HRMY) stake by 6.8% in Q2 2026, buying an estimated $66.2K and bringing the position to 33,200 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #983.

Canada Pension Plan Investment Board first reported a position in HRMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.92M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Canada Pension Plan Investment Board held 33,200 shares of Harmony Biosciences worth $1.21M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 2,100 Harmony Biosciences shares in Q2 2026, an estimated $66.2K.
  • Harmony Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #983 holding.
  • Canada Pension Plan Investment Board first reported a position in Harmony Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Canada Pension Plan Investment Board's Harmony Biosciences position peaked at $1.92M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.